Tulbah, A. S. “Formulation and in Vitro Characterization of Inhalable Dasatinib-Nanoemulsion As a Treatment Potential Against A549 and Calu-3 Lung Cancer Cells”. International Journal of Health Sciences, vol. 19, no. 1, Jan. 2025, pp. 4-14, https://pub.qu.edu.sa/index.php/journal/article/view/8643.